---

David Schenkein

Chief Executive Officer, Agios Pharmaceuticals 

David joined Agios in August 2009 as CEO and board member, after working as senior vice president, clinical hematology/oncology, at Genentech. He has been a hematologist and medical oncologist for more than 20 years and still sees patients once a week at Tufts Medical Center, where he started practicing as a doctor in 1983.

---

Part of the Power List 2018

The World’s Top 100 Medicine Makers

Bringing new drugs to patients is an incredibly difficult task that involves numerous indispensable actors – from pioneering entrepreneurs and CEOs, to industry experts, to dedicated researchers, to regulators who keep everyone on the right tracks.

Go to The Power List 2018